{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:19:52Z","timestamp":1778105992489,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40268-020-00302-7","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T02:02:31Z","timestamp":1586311351000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2404-9717","authenticated-orcid":false,"given":"Mwila","family":"Mulubwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heletje Aletta","family":"Griesel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5653-0551","authenticated-orcid":false,"given":"Pierre","family":"Mugabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricky","family":"Dippenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizelle","family":"van Wyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"key":"302_CR1","doi-asserted-by":"publisher","first-page":"e32863","DOI":"10.1371\/journal.pone.0032863","volume":"7","author":"P Tissieres","year":"2012","unstructured":"Tissieres P, Ochoda A, Dunn-Siegrist I, Drifte G, Morales M, Pfister R, et al. Innate immune deficiency of extremely premature neonates can be reversed by interferon-gamma. PLoS One. 2012;7:e32863.","journal-title":"PLoS One"},{"key":"302_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(05)71881-X","volume":"365","author":"AKM Zaidi","year":"2005","unstructured":"Zaidi AKM, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365:1175\u201388.","journal-title":"Lancet"},{"key":"302_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2431-10-39","volume":"10","author":"N Kayange","year":"2010","unstructured":"Kayange N, Kamugisha E, Mwizamholya DL, Jeremiah S, Mshana SE. Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC Pediatr. 2010;10:39.","journal-title":"BMC Pediatr"},{"key":"302_CR4","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1001\/jama.292.19.2357","volume":"292","author":"BJ Stoll","year":"2004","unstructured":"Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357\u201365.","journal-title":"JAMA"},{"key":"302_CR5","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"302_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/INF.0000000000001943","volume":"37","author":"A Alsultan","year":"2018","unstructured":"Alsultan A, Abouelkheir M, Alqahtani S, Aljabri A, Somily AM, Alsubaie S, et al. Vancomycin monitoring in pediatric patients. Pediatr Infect Dis J. 2018;37:880\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"302_CR7","doi-asserted-by":"publisher","first-page":"e01293\u201317","DOI":"10.1128\/AAC.01293-17","volume":"61","author":"NA Finch","year":"2017","unstructured":"Finch NA, Zasowski EJ, Murray KP, Mynatt RP, Zhao JJ, Yost R, et al. A quasi-experiment to study the impact of vancomycin area under the concentration-time curve-guided dosing on vancomycin-associated nephrotoxicity. Antimicrob Agents Chemother. 2017;61:e01293\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"302_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/phar.2234","volume":"39","author":"L Meng","year":"2019","unstructured":"Meng L, Wong T, Huang S, Mui E, Nguyen V, Espinosa G, et al. Conversion from vancomycin trough concentration-guided dosing to area under the curve-guided dosing using two sample measurements in adults: implementation at an Academic Medical Center. Pharmacotherapy. 2019;39:433\u201342.","journal-title":"Pharmacotherapy"},{"key":"302_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jiac.2016.11.009","volume":"23","author":"H Kato","year":"2017","unstructured":"Kato H, Hagihara M, Nishiyama N, Koizumi Y, Mikamo H, Matsuura K, et al. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates. J Infect Chemother. 2017;23:154\u201360.","journal-title":"J Infect Chemother"},{"key":"302_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-2125.2010.03736.x","volume":"70","author":"MR Marques-Minana","year":"2010","unstructured":"Marques-Minana MR, Saadeddin A, Peris JE. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline. Br J Clin Pharmacol. 2010;70:713\u201320.","journal-title":"Br J Clin Pharmacol"},{"key":"302_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/PCC.0000000000001250","volume":"18","author":"JJ Cies","year":"2017","unstructured":"Cies JJ, Moore WS, Nichols K, Knoderer CA, Carella DM, Chopra A. Population pharmacokinetics and pharmacodynamic target attainment of vancomycin in neonates on extracorporeal life support. Pediatr Crit Care Med. 2017;18:977\u201385.","journal-title":"Pediatr Crit Care Med"},{"key":"302_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1128\/AAC.31.1.52","volume":"31","author":"A James","year":"1987","unstructured":"James A, Koren G, Milliken J, Soldin S, Prober C. Vancomycin pharmacokinetics and dose recommendations for preterm infants. Antimicrob Agents Chemother. 1987;31:52\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"302_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11096-018-0589-9","volume":"40","author":"TBY Liem","year":"2018","unstructured":"Liem TBY, Slob EMA, Termote JUM, Wolfs TFW, Egberts ACG, Rademaker CMA. Comparison of antibiotic dosing recommendations for neonatal sepsis from established reference sources. Int J Clin Pharm. 2018;40:436\u201343.","journal-title":"Int J Clin Pharm"},{"key":"302_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0022-3476(05)82056-6","volume":"119","author":"J Ballard","year":"1991","unstructured":"Ballard J, Khoury J, Wedig K, Wang L, Eilers-Walsman B, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119:417\u201323.","journal-title":"J Pediatr"},{"key":"302_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/jp.2010.82","volume":"31","author":"MW Walker","year":"2011","unstructured":"Walker MW, Clark RH, Spitzer AR. Elevation in plasma creatinine and renal failure in premature neonates without major anomalies: terminology, occurrence and factors associated with increased risk. J Perinatol. 2011;31:199\u2013205.","journal-title":"J Perinatol"},{"key":"302_CR16","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0022-3476(86)80245-1","volume":"109","author":"LP Brion","year":"1986","unstructured":"Brion LP, Fleischman AR, McCarton C, Schwartz GJ. A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: noninvasive assessment of body composition and growth. J Pediatr. 1986;109:698\u2013707.","journal-title":"J Pediatr"},{"key":"302_CR17","first-page":"14","volume":"81","author":"General Assembly of the World Medical Association","year":"2014","unstructured":"General Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81:14\u20138.","journal-title":"J Am Coll Dent"},{"key":"302_CR18","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/jac\/dky525","volume":"74","author":"E Germovsek","year":"2019","unstructured":"Germovsek E, Osborne L, Gunaratnam F, Lounis SA, Busquets FB, Standing JF, et al. Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data. J Antimicrob Chemother. 2019;74:1003\u201311.","journal-title":"J Antimicrob Chemother"},{"key":"302_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2133\/dmpk.24.25","volume":"24","author":"BJ Anderson","year":"2009","unstructured":"Anderson BJ, Holford NHG. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet. 2009;24:25\u201336.","journal-title":"Drug Metab Pharmacokinet"},{"key":"302_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66:82\u201398.","journal-title":"Am J Health Syst Pharm"},{"key":"302_CR21","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00228-018-2454-0","volume":"74","author":"Y Chen","year":"2018","unstructured":"Chen Y, Wu D, Dong M, Zhu Y, Lu J, Li X, et al. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants. Eur J Clin Pharmacol. 2018;74:921\u201330.","journal-title":"Eur J Clin Pharmacol"},{"key":"302_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/j.1875-9114.2012.01029.x","volume":"32","author":"N Mehrotra","year":"2012","unstructured":"Mehrotra N, Tang L, Phelps SJ, Meibohm B. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations. Pharmacotherapy. 2012;32:408\u201319.","journal-title":"Pharmacotherapy"},{"key":"302_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/archdischild-2012-302765","volume":"98","author":"W Zhao","year":"2013","unstructured":"Zhao W, Lopez E, Biran V, Durrmeyer X, Fakhoury M, Jacqz-Aigrain E. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring. Arch Dis Child. 2013;98:449\u201353.","journal-title":"Arch Dis Child"},{"key":"302_CR24","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1128\/AAC.02564-13","volume":"58","author":"W Zhao","year":"2014","unstructured":"Zhao W, Zhang D, Fakhoury M, Fahd M, Duquesne F, Storme T, et al. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease. Antimicrob Agents Chemother. 2014;58:3191\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"302_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1128\/AAC.44.2.278-282.2000","volume":"44","author":"P Lamarre","year":"2000","unstructured":"Lamarre P, Lebel D, Ducharme MP. A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population. Antimicrob Agents Chemother. 2000;44:278\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"302_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/0310057X9302100206","volume":"21","author":"P Marik","year":"1993","unstructured":"Marik P. Aminoglycoside volume of distribution and illness severity in critically ill septic patients. Anaesth Intensive Care. 1993;21:172\u20133.","journal-title":"Anaesth Intensive Care."},{"issue":"suppl_B","key":"302_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jac\/32.suppl_B.117","volume":"32","author":"H Kieft","year":"1993","unstructured":"Kieft H, Hoepelman A, Knupp C, Van Dijk A, Branger J, Struyvenberg A, et al. Pharmacokinetics of cefepime in patients with the sepsis syndrome. J Antimicrob Chemother. 1993;32(suppl_B):117\u201322.","journal-title":"J Antimicrob Chemother."},{"key":"302_CR28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1034\/j.1399-6576.1999.430707.x","volume":"43","author":"G Tang","year":"1999","unstructured":"Tang G, Tang J, Lin B, Kong C, Lee T. Factors affecting gentamicin pharmacokinetics in septic patients. Acta Anaesthesiol Scand. 1999;43:726\u201330.","journal-title":"Acta Anaesthesiol Scand"},{"key":"302_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.18773\/austprescr.2015.034","volume":"38","author":"M Harrison","year":"2015","unstructured":"Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Aust Prescr. 2015;38:93\u20134.","journal-title":"Aust Prescr"},{"key":"302_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40121-015-0067-9","volume":"4","author":"C Stockmann","year":"2015","unstructured":"Stockmann C, Hersh AL, Roberts JK, Bhongsatiern J, Korgenski EK, Spigarelli MG, et al. Predictive performance of a vancomycin population pharmacokinetic model in neonates. Infect Dis Ther. 2015;4:187\u201398.","journal-title":"Infect Dis Ther"},{"key":"302_CR31","first-page":"338","volume":"7","author":"AJ Hsu","year":"2018","unstructured":"Hsu AJ, Hamdy RF, Huang Y, Olson JA, Ghobrial S, Gerber JS, et al. Association between vancomycin trough concentrations and duration of methicillin-resistant Staphylococcus aureus bacteremia in children. J Pediatr Infect Dis Soc. 2018;7:338\u201341.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"302_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jac\/dkg269","volume":"52","author":"K Drlica","year":"2003","unstructured":"Drlica K. The mutant selection window and antimicrobial resistance. J Antimicrob Chemother. 2003;52:11\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"302_CR33","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1097\/INF.0b013e318286378e","volume":"32","author":"J Le","year":"2013","unstructured":"Le J, Bradley JS, Murray W, Romanowski GL, Tran TT, Nguyen N, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J. 2013;32:e155\u201363.","journal-title":"Pediatr Infect Dis J"},{"key":"302_CR34","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/INF.0b013e318299f75c","volume":"32","author":"A Frymoyer","year":"2013","unstructured":"Frymoyer A, Guglielmo BJ, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. Pediatr Infect Dis J. 2013;32:1077\u20139.","journal-title":"Pediatr Infect Dis J"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00302-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-020-00302-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-020-00302-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T23:22:27Z","timestamp":1617837747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-020-00302-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1007\/s40268-020-00302-7","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,8]]},"assertion":[{"value":"8 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No specific funding was received for the conduct of this study or preperation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mwila Mulubwa, Heletje Aletta Griesel, Pierre Mugabo, Ricky Dippenaar, and Lizelle van Wyk have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The ethics committee of the University of the Western Cape approved the study (certificate number: 12\/2\/21). Permission was sought from the research department of Netcare hospital (reference: UNIV-2012-0008) to conduct the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the parents of each premature infant before enrolment in the study. Strict confidentiality was observed, and the study was carried out in accordance with the principles outlined in the Declaration of Helsinki. The parents had the right to withdraw their infants from the study at any time without giving a reason.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}